Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

XIHPOS™ ZFUZE™ Interbody Fusion System

K-Number: K190544 · 2019-11-01

Decision Date2019-11-01
Product CodeMAX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

XIHPOS™ ZFUZE™ Interbody Fusion System is a medical device manufactured by Difusion Technologies. It received FDA 510(k) clearance on 2019-11-01 under approval number K190544. The device is classified under product code MAX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the XIHPOS™ ZFUZE™ Interbody Fusion System?

XIHPOS™ ZFUZE™ Interbody Fusion System is a medical device that received FDA 510(k) clearance on 2019-11-01. It is manufactured by Difusion Technologies. The 510(k) number is K190544.

When was XIHPOS™ ZFUZE™ Interbody Fusion System approved by the FDA?

XIHPOS™ ZFUZE™ Interbody Fusion System received FDA 510(k) clearance on 2019-11-01, under approval number K190544.

What company makes XIHPOS™ ZFUZE™ Interbody Fusion System?

XIHPOS™ ZFUZE™ Interbody Fusion System is manufactured by Difusion Technologies.

What is the FDA product code for XIHPOS™ ZFUZE™ Interbody Fusion System?

The FDA product code for XIHPOS™ ZFUZE™ Interbody Fusion System is MAX.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: MAX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.